Dr. Maury Nelson Blitman, MD

Dr. Blitman practices at Cancer Care Northwest - 1204 N Vercler Rd in Spokane Valley, Washington.

Dr. Blitman's NPI, 1396713095, was assigned on March 9, 2006. Dr. Blitman graduated from Hahnemann University College of Medicine in 1986. Dr. Blitman holds Washington license MD00048643.

Dr. Blitman's primary practice is Cancer Care Northwest - 1204 N Vercler Rd, at 1204 N Vercler Rd, Spokane Valley, WA 99216 in Spokane County. The practice phone is (509) 228-1000.

Dr. Blitman's primary practice is Cancer Care Northwest - 1204 N Vercler Rd in Spokane Valley, Washington. Dr. Blitman is also affiliated with Providence Mount Carmel Hospital. The medical group on file is Cancer Care Northwest. Dmand AI also links Dr. Blitman to 2 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blitman practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Blitman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Blitman's licenses on file in 3 states: Washington, New Mexico and Oregon.

CMS data shows 23,182 Medicare services from Dr. Blitman across 32 procedure codes in 2024, for 498 Medicare patients. Medicare paid $575,263 for them. Every service was in an office.

CMS counts 498 Medicare patients who saw Dr. Blitman in 2024. The largest group is 75 to 84, with 193 patients. 67% of them have high blood pressure, and 60% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blitman's median patient age at 72, with 42% women.

In 2024, Dr. Blitman wrote 1,124 Medicare Part D claims for 199 patients. 66% of them were for generic drugs. CMS names the drug for 910 of them, across 34 drugs with 11 or more claims each, at $4,876,218 in total drug cost. In 2023, CMS named 874 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Blitman for performance year 2024, reported as part of a group. Dr. Blitman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 184 general payments to Dr. Blitman from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Janssen Pharmaceuticals, Inc paid the most, $382.

Dr. Blitman graduated from Hahnemann University College of Medicine in 1986.